25.10.2014 Views

Annual Report 2011-12.pdf - Performance Management Division

Annual Report 2011-12.pdf - Performance Management Division

Annual Report 2011-12.pdf - Performance Management Division

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Quality <strong>Management</strong> System<br />

National Dope Testing Laboratory has developed and implemented its <strong>Management</strong> System to<br />

ensure quality of sample testing meeting the regulatory requirements and its customer's<br />

expectations. The quality manual has been developed in accordance with the ISO/IEC17025:2005<br />

Standard and International Standard for Laboratories (Version 6.0) January 2009. The sample<br />

testing methodology is adopted as per WADA guidelines and the testing methods are upgraded as<br />

per the need.<br />

External and internal audits are carried out on regular basis as per National Accreditation Board<br />

of Laboratories (NABL) requirements for the continuation of ISO/IEC17025:2005 accreditation.<br />

ISO Surveillance audit (External Audit)<br />

The ISO Surveillance audit of Biological activities and Desktop audit of Chemical activities was<br />

nd<br />

held on 21-22 September <strong>2011</strong>. The two member audit team recommended for the continuation of<br />

accreditation, which was later approved by NABL accreditation committee.<br />

Internal audit<br />

In order to review the functional status and quality system of NDTL, internal audits were<br />

conducted by trained internal assessors as per the approved annual schedule.<br />

WADA-Indian Pharmaceutical Companies Cooperation<br />

WADA-Indian Pharmaceutical Companies Cooperation was done to explore the possibility of<br />

cooperation between WADA and Indian Pharmaceutical companies on voluntary basis to share<br />

information which would show India's further commitment to be in the forefront of its mission to<br />

fight against doping. In this regard, Dr. Olivier Rabin, WADA Director, Science visited NDTL<br />

st<br />

st<br />

India on 31 October-1 November, <strong>2011</strong> to have a meeting with Pharmaceutical Companies in<br />

India (Ranbaxy Pharmaceuticals, Cipla, Dr. Reddy's Lab), renowned pharmacologists from All<br />

India Institute of Medical Sciences (AIIMS), Indian Council of Medical Research (ICMR), Indian<br />

Pharmacopeial Commission, and officials of NADA.<br />

Bilateral Cooperation<br />

A. International<br />

NDTL has entered in bilateral cooperation with two premier labs in the world which are Drug<br />

Control Centre, Kings College, and London and Anti doping lab, Rome, Italy.<br />

In addition, the possibility of cooperation with other WADA accredited anti-doping laboratory in<br />

South Africa is being explored. Areas of cooperation would include sharing of knowledge for<br />

improvement in testing protocol, exchange of staff between institutes and to work on research<br />

projects.<br />

98 ✦ Department of Youth Affairs & Sports

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!